SEC Comment Letter for Nutex Health, Inc. (NUTX) (CIK 0001479681) (NUTX) — Sep 27, 2018
Nutex Health, Inc. (NUTX) (CIK 0001479681)
Date: Sept. 27, 2018 · CIK: 0001479681 · Accession: 0000000000-18-030431
AI Filing Summary & Sentiment
Letter
Mail Stop 3561 September 26, 2018 John Salerno Chief Executive Officer iGambit, Inc. 1050 W. Jericho Turnpike, Suite A Smithtown, NY 11787
Re: iGambit, Inc. Information Statement on Schedule 14C Filed August 9, 2018 File No. 0 -53862
Dear Mr. Salerno :
We have completed our review of your filing . We remind you that the company and its management are responsible for the accuracy and adequacy of the ir disclosure s, notwithstanding any review, comments, action or absence of action by the staff .
Sincerely,
/s/ Mara L. R ansom
Show Raw Text
Mail Stop 3561 September 26, 2018 John Salerno Chief Executive Officer iGambit, Inc. 1050 W. Jericho Turnpike, Suite A Smithtown, NY 11787 Re: iGambit, Inc. Information Statement on Schedule 14C Filed August 9, 2018 File No. 0 -53862 Dear Mr. Salerno : We have completed our review of your filing . We remind you that the company and its management are responsible for the accuracy and adequacy of the ir disclosure s, notwithstanding any review, comments, action or absence of action by the staff . Sincerely, /s/ Mara L. R ansom Mara L. Ransom Assistant Director Office of Consumer Products